Reviva Pharmaceuticals Holdings, Inc. (RVPH): Kompaniyaning buxgalteriya qiymati
Ushbu grafikda ko'rsatilgan Reviva Pharmaceuticals (RVPH) aksiyalarining joriy narxi innovatsion Brilaroxazine ni joriy etish orqali ruhiy buzilishlarga qarshi kurashish uchun kompleks tizimni ishlab chiqayotgan kompaniyaning dinamikasini aks ettiradi. Joriy ko'rsatkich 0.02 darajasida turibdi. Biznes hozirda klinik sinovlar bosqichida bo'lgan shizofreniya uchun xavfsiz davolash usulini ishlab chiqishga tayanadi. Shu bilan birga, pragmatik boshqaruv ushbu mikro-kapitallashgan kompaniyaning cheklangan kapitaliga qaramay, ma'lumotlar shaffofligini ta'minlaydi.
%20Kompaniyaning%20balans%20qiymati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_RVPH_-_Reviva-Pharmaceuticals_-_Company-Book-Value "Reviva Pharmaceuticals Holdings Inc. (RVPH) Buxgalteriya kapitallashuvi: 04.07.2022 - 16.05.2026 davri uchun | 👁️GURU.Markets👁️")
Reviva Pharmaceuticals Holdings, Inc. (RVPH) kompaniyasi koʻrsatkichlari kesimi va tahlili
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Reviva Pharmaceuticals|RVPH - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Reviva Pharmaceuticals Holdings Inc.|RVPH - Kompaniya qarzlari|Balans qiymatiga qarzlar Reviva Pharmaceuticals Holdings Inc.|RVPH - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli kredit va qarzlari Reviva Pharmaceuticals
Kompaniyaning jamlanma tahlili:Reviva Pharmaceuticals, Inc. - RVPH
Balans qiymati kompaniyaning barcha majburiyatlari chegirib tashlangan sof aktivlar qiymatini aks ettiradi va biznesning moddiy barqarorligining fundamental ko'rsatkichi bo'lib xizmat qiladi. Selektiv MKS terapiyasiga investitsiya kiritayotgan Reviva Pharmaceuticals (RVPH) uchun balans qiymati tendentsiyasi kompaniyaning shizofreniyaga qarshi dori vositalarini ishlab chiqishni moliyalashtirish qobiliyatini namoyish etib, uning resurslar bazasi sifatini va defoltga qarshi himoyalanganligini tasdiqlaydi.
Reviva Pharmaceuticals raqobatchilari
BIIB - Sof aktivlar qiymati|Balans kapitallashuvi Neurocrine Biosciences NBIX|RGC (regencellbioscience.com) - Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati Axsome Therapeutics, Inc. (AXSM)|Buxgalteriya kapitallashuvi ACADIA Pharma|Xenon Pharmaceuticals Inc - Balans kapitallashuvi|Kompaniyaning xususiy kapitali Viking Therapeutics Corp VKTX|Kompaniyaning sof aktivlari SUPN (Supernus Pharmaceuticals)|catalystpharma.com - Balans kapitallashuvi|Kompaniyaning balans qiymati Denali Therapeutics Inc. (DNLI)|HRMY: Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati BHVN|AMLX (Amylyx Corp) - Kompaniyaning xususiy kapitali|TRVI - Kompaniyaning balans qiymati|Kompaniyaning buxgalteriya qiymati praxismedicines.com|Anavex Life Sciences Corp. - Balans kapitallashuvi|Kompaniyaning xususiy kapitali CeriBell Inc CBLL|Kompaniyaning sof aktivlari prothena.com PRTA|Kompaniyaning balans qiymati Alector Inc. ALEC|Balans kapitallashuvi ANNX (Annexon, Inc.)|Omeros Corporation (OMER) - Biznesning balans bahosi|Neurogene (NGNE) - Kompaniyaning sof aktivlari|AC Immune S.A. (ACIU) - Kompaniyaning balans qiymati|VYGR (Voyager Pharma) - Balans kapitallashuvi|Balans kapitallashuvi Neumora Corp (NMRA)|Scilex Holding Company (SCLX) - Kompaniyaning sof aktivlari|Kompaniyaning buxgalteriya qiymati TVGN (tevogen.com)|Alpha Cognition Inc. (ACOG) - Kompaniyaning balans qiymati|Sof aktivlar qiymati cogrx.com CGTX|Balans kapitallashuvi Inhibikase (IKT)|SAVA - Kompaniyaning buxgalteriya qiymati|ASRT: Balans kapitallashuvi|COYA (Coya Therapeutics) - Balans kapitallashuvi|VTGN - Kompaniyaning balans qiymati|Kompaniyaning buxgalteriya qiymati OVID|Kompaniyaning balans qiymati ABOS (Acumen Pharma)|Kompaniyaning sof aktivlari CervoMed Corporation (CRVO)|Balans kapitallashuvi ATHE (Alterity Therapeutics Limited)|Balans kapitallashuvi Clene Inc CLNN|PEPG: Balans kapitallashuvi|JUNS - Kompaniyaning sof aktivlari|Balans kapitallashuvi RLMD|Kompaniyaning xususiy kapitali Annovis Bio Corporation|GRCE (Grace Therapeutics Inc) - Kompaniyaning sof aktivlari|Balans kapitallashuvi fireflyneuro.com (AIFF)|Kompaniyaning sof aktivlari Klotho Neurosciences Inc|Jami sof aktivlar neurosense-tx.com (NRSN)|Balans kapitallashuvi MTVA|Biznesning balans bahosi NeurAxis Inc NRXS|HSDT: Balans kapitallashuvi|PASG - Kompaniyaning sof aktivlari|NEUP: Balans kapitallashuvi|NERV (Minerva Neurosciences Inc) - Balans kapitallashuvi|Kompaniyaning balans qiymati Athira|Kompaniyaning balans qiymati ADXN|ALZN (Alzamend Neuro, Inc.) - Kompaniyaning balans qiymati|Biznesning balans bahosi CYCN (cyclerion.com)|Kompaniyaning balans qiymati Protagenic Therapeutics, Inc.|KTTA - Kompaniyaning buxgalteriya qiymati|CRGT - Kompaniyaning sof aktivlari|ATXI: Kompaniyaning balans qiymati|Kompaniyaning balans qiymati Brainstorm Cell (BCLI)|caratherapeutics.com (CARA) - Sof aktivlar qiymati|CHRO - Balans kapitallashuvi|Kompaniyaning buxgalteriya qiymati ELYM|Kompaniyaning balans qiymati Intra-Cellular Therapies ITCI|Buxgalteriya kapitallashuvi Longboard (LBPH)|MRNS: Balans kapitallashuvi|NKGN - Kompaniyaning xususiy kapitali|NeuroBo Pharmaceuticals, Inc. - Kompaniyaning sof aktivlari|SAGE: Balans kapitallashuvi|Kompaniyaning balans qiymati Neurotrope SNPX|TRVN (Trevena Inc) - Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati VIGL (Vigil Neuroscience Inc.)|Kompaniyaning xususiy kapitali WENA|Cerevel Therapeutics, Inc. (CERE) - Kompaniyaning balans qiymati